Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Helius Medical Technologies Inc (NASDAQ: HSDT) was $15.22 for the day, down -5.05% from the previous closing price of $16.03. In other words, the price has decreased by -$5.05 from its previous closing price. On the day, 0.62 million shares were traded. HSDT stock price reached its highest trading level at $16.5 during the session, while it also had its lowest trading level at $13.1.
Ratios:
Our analysis of HSDT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.69 and its Current Ratio is at 4.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Noble Capital Markets on March 24, 2021, initiated with a Outperform rating and assigned the stock a target price of $20.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HSDT now has a Market Capitalization of 16395852 and an Enterprise Value of 10317852. For the stock, the TTM Price-to-Sale (P/S) ratio is 56.54 while its Price-to-Book (P/B) ratio in mrq is 1.72. Its current Enterprise Value per Revenue stands at 34.976 whereas that against EBITDA is -0.748.
Stock Price History:
The Beta on a monthly basis for HSDT is 0.97, which has changed by -0.97020066 over the last 52 weeks, in comparison to a change of 0.15535986 over the same period for the S&P500. Over the past 52 weeks, HSDT has reached a high of $1200.00, while it has fallen to a 52-week low of $5.37. The 50-Day Moving Average of the stock is 71.75%, while the 200-Day Moving Average is calculated to be -93.25%.
Shares Statistics:
HSDT traded an average of 763.08K shares per day over the past three months and 2692020 shares per day over the past ten days. A total of 1.08M shares are outstanding, with a floating share count of 0.93M. Insiders hold about 14.11% of the company’s shares, while institutions hold 1.14% stake in the company. Shares short for HSDT as of 1756425600 were 15282 with a Short Ratio of 0.02, compared to 1753920000 on 40996. Therefore, it implies a Short% of Shares Outstanding of 15282 and a Short% of Float of 1.4199998999999999.
Earnings Estimates
. The current market rating for Helius Medical Technologies Inc (HSDT) reflects the collective analysis of 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$26.5, with high estimates of -$26.5 and low estimates of -$26.5.
Analysts are recommending an EPS of between -$253.5 and -$253.5 for the fiscal current year, implying an average EPS of -$253.5. EPS for the following year is -$64.5, with 1.0 analysts recommending between -$64.5 and -$64.5.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 1 analysts. It ranges from a high estimate of $110k to a low estimate of $110k. As of. The current estimate, Helius Medical Technologies Inc’s year-ago sales were $51kFor the next quarter, 1 analysts are estimating revenue of $140k. There is a high estimate of $140k for the next quarter, whereas the lowest estimate is $140k.
A total of 1 analysts have provided revenue estimates for HSDT’s current fiscal year. The highest revenue estimate was $374k, while the lowest revenue estimate was $374k, resulting in an average revenue estimate of $374k. In the same quarter a year ago, actual revenue was $520kBased on 1 analysts’ estimates, the company’s revenue will be $655k in the next fiscal year. The high estimate is $655k and the low estimate is $655k.
